OTC: KNTPF - Kintor Pharmaceutical Limited

Rentabilidad a seis meses: +85%
Sector: Healthcare

Calendario de promoción Kintor Pharmaceutical Limited


Acerca de la empresa

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally.

Más detalles
The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline comprises ALK-1 antibody for the treatment of metastatic hepatocellular carcinoma (HCC) and various solid tumours; GT20029, a topical AR-PROTAC compound for the treatment of AGA and acne vulgaris; and PD-L1/TGF-ß, a dual target antibody to treat non-small cell lung cancer, biliary tract cancer, triple negative breast cancer, and HPV-associated tumours. In addition, the company's products pipeline include Detorsertib for the treatment of metastatic solid tumours, such as breast cancer, prostate cancer, and HCC; and Hedgehog/SMO Inhibitor, an inhibitor of the hedgehog signal transduction pathway to treat blood cancer. Kintor Pharmaceutical Limited was founded in 2009 and is headquartered in Suzhou, the People's Republic of China.

EBITDA -1.58
EV/EBITDA 0.5813
Industry Biotechnology
P/BV 0.2533
P/S 114.48
Sector Health Care
Валюта usd
Валюта отчета cny
Выручка 0.2181
Сайт https://www.kintor.com.cn
Цена ао 0.1088
Число акций ао 0.42907 млрд
Cambio de precio por día: 0% (0.185)
Cambio de precio por semana.: 0% (0.185)
Cambio de precio por mes: +121.56% (0.0835)
Cambio de precio en 3 meses.: +101.09% (0.092)
Cambio de precio en seis meses: +85% (0.1)
Cambio de precio por año: -51.01% (0.3776)
Cambio de precio en 3 años.: -97.94% (9)
Cambio de precio desde principios de año.: -52.26% (0.3875)

Subestimación

Nombre Significado Calificación
P/S 0 0
P/BV 1.05 9
P/E 0 0
EV/EBITDA -0.274 0
Total: 3.63

Eficiencia

Nombre Significado Calificación
ROA, % -122.04 0
ROE, % -231.56 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0

Deber

Nombre Significado Calificación
Debt/EBITDA -0.2383 10
Total: 10

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 4804.15 10
Rentabilidad Ebitda, % 366.98 10
Rentabilidad EPS, % 310.9 10
Total: 8.8



Supervisor Título profesional Pago año de nacimiento
Dr. Youzhi Tong Founder, CEO & Executive Chairman 983.28k 1962 (62 año)
Mr. Ming Ming Cheung Joint Company Secretary & CFO N/A 1977 (47 años)
Dr. Xiang Ni Chief Medical Officer & Executive Director N/A 1969 (55 años)
Mr. Wai Chiu Wong FCS Company Secretary N/A 1955 (69 años)

DIRECCIÓN: China, Suzhou, No. 20 Songbei Road - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.kintor.com.cn